Sensorion (STU:RFM) Float Percentage Of Total Shares Outstanding: 0.00% (As of Jul. 11, 2026)


STU:RFM Sensorion SA STU:RFM
29 GF Score
Price €0.26
GF Value €0.43
Valuation Possible Value Trap
! 1 Warning Sign
View Full Analysis

What is Sensorion Float Percentage Of Total Shares Outstanding?

Sensorion STU:RFM +2.15% 29 Float Percentage Of Total Shares Outstanding is 0.00% as of Jul. 11, 2026. GuruFocus rates STU:RFM with a GF Score™ of 29/100 and a GF Value™ of €0.43 (Possible Value Trap). The stock has 1 warning sign investors should review.

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Sensorion's float shares is 0.00 Mil. Sensorion's total shares outstanding is 515.13 Mil. Sensorion's float percentage of total shares outstanding is 0.00%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Sensorion's Insider Ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Sensorion's Institutional Ownership is 7.24%.

STU:RFM
29GF Score
Sensorion SA STU:RFM
Float Percentage Of Total Shares Outstanding is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sensorion Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Sensorion's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=0.00/515.13
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Float Percentage Of Total Shares Outstanding of 0.00% mean?
Sensorion (STU:RFM) has a Float Percentage Of Total Shares Outstanding of 0.00% as of Jul. 11, 2026. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on Sensorion and its competitors.
Is Sensorion's Float Percentage Of Total Shares Outstanding too high?
Sensorion's current Float Percentage Of Total Shares Outstanding is 0.00%. Overall, Sensorion has a GF Score™ of 29/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Sensorion's Float Percentage Of Total Shares Outstanding compare to VRTX and REGN?
Sensorion's Float Percentage Of Total Shares Outstanding of 0.00% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Float Percentage Of Total Shares Outstanding for a Biotechnology company?
A good Float Percentage Of Total Shares Outstanding depends on the Biotechnology industry context. However, Float Percentage Of Total Shares Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Float Percentage Of Total Shares Outstanding mean?
A high Float Percentage Of Total Shares Outstanding can signal that a stock is expensive relative to its fundamentals. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on Sensorion and its competitors. Sensorion's current Float Percentage Of Total Shares Outstanding is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sensorion stock overvalued right now?
Based on GuruFocus' analysis, Sensorion (STU:RFM) is currently considered Possible Value Trap. The stock's GF Value™ is €0.43, compared to a current price of €0.26 — trading 39.2% below its estimated fair value. The current Float Percentage Of Total Shares Outstanding is 0.00%. Sensorion's overall GF Score™ is 29/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Float Percentage Of Total Shares Outstanding calculated?
Float Percentage Of Total Shares Outstanding is calculated from a company's financial statements. For Sensorion (STU:RFM), the current Float Percentage Of Total Shares Outstanding is 0.00% as of Jul. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sensorion (STU:RFM) Overvalued in 2026?

Based on GuruFocus' analysis, Sensorion stock appears to be undervalued. The current stock price of €0.26 is trading 39.2% below its estimated GF Value™ of €0.43. GuruFocus considers Sensorion to be Possible Value Trap.

Key valuation signals for STU:RFM:

  • Float Percentage Of Total Shares Outstanding: 0.00%
  • GF Value™: €0.43 vs. price of €0.26 (39.2% below fair value)
  • GF Score™: 29/100 with 1 warning sign

No single metric tells the full story. See the STU:RFM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Sensorion Business Description

Other Exchanges ALSEN:France
Address 375, rue du Professeur Joseph Blayac, Montpellier, FRA, 34080
Sensorion SA is a France-based clinical-stage biotech company, which specializes in the development of novel therapies to restore, treat, and prevent hearing loss disorders. The SENS501 (OTOF-GT) targets deafness caused by mutations of the gene encoding for otoferlin and is currently developed in a Phase 1/2 clinical study, and GJB2-GT targets hearing loss related to mutations in GJB2 gene to potentially address important hearing loss segments in adults and children. The Company is also working on the identification of biomarkers to improve diagnosis of these underserved illnesses. The company's pipeline programs are OTOF-GT (SENS-501), GJB2-GT, GJB2-GT, GJB2-GT, TREAT AND PREVENT, SENS-401 COCHLEAR, SENS-401 CIO, and SENS-401 SSNHL.
29GF Score

Get the complete analysis for STU:RFM

Float Percentage Of Total Shares Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.26
Price
€0.43
GF Value